Drugs / Rabeprazole sodium enteric-coated tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06481371 | Jun 2024 → Feb 2025 | depressive disorder, dyspepsia | Nanjing First Hospital, Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabeprazole sodium enteric-coated tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06481371 ↗ |